Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Product Information Update- Innohep 20,000 IU/ml vial and syringes (tinzaparin sodium)
Notice type:
3rd Party Publications
Date:
15/11/2016
Update to the Prescribing Information following a European Union (EU) harmonisation work-sharing procedure.
Product name or type:
Innohep 20,000 IU/ml vial and syringes (20,000 IU/ml; 8000 IU in 0.4 ml; 10,000 IU in 0.5 ml; 12,000 IU in 0.6 ml; 14,000 IU in 0.7 ml; 16,000 IU in 0.8 ml; 18,000 IU in 0.9 ml;) for SC injection
Authorisation Number:
PA0046/060/003-4; PA0046/060/010-14
Authorisation Holder:
Leo Pharma
Further Information:
Product Information Update- Innohep 20,000 IU/ml vial and syringes (tinzaparin sodium)
« Back
Date Printed: 18/05/2024